Interfering with ZEB1 expression has been demonstrated to increase the sensitivity of colorectal cancer cells to chemotherapy, suggesting that reducing ZEB1 expression may help restore sensitivity in ZEB1-mediated chemotherapy resistance [108]. This evidence concerns the gene ZEB1 and colorectal cancer.